Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02990845
Status:
TERMINATED
Last Update Posted:
2023-02-22
First Post:
2016-12-01
Brief Title:
Pembrolizumab and Exemestane Leuprolide in Premenopausal HR HER2- Locally Advanced or Metastatic Breast Cancer
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Organization Data
Organization:
National Taiwan University Hospital
Class:
OTHER
Study ID:
201610003MIFA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Taiwan University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |